Estrategia En Ictus Del Sistema Nacional De Salud

Objectives

Spain’s Stroke Strategy for the National Health System seeks to reduce stroke-related mortality, disability, dependency and social burden by improving the quality, timeliness and equity of prevention, acute care, rehabilitation and reintegration across the country. It was approved by the Interterritorial Council of the National Health System on 26 November 2008 and is framed within the National Health System Quality Plan.[1][2][3]The strategy is grounded in universal, publicly financed, equitable, integrated and continuous health services.[4]

• Reduce stroke incidence and recurrence through health promotion, protection, primary prevention and secondary prevention, particularly through detection and management of modifiable vascular risk factors.[2][5][6]
• Improve public recognition of stroke warning symptoms, risk factors and the need to contact emergency services immediately, reducing delays before specialist assessment and treatment.[1][7][8]
• Provide rapid, coordinated acute care that limits brain injury, enables treatment decisions within 60 minutes of hospital arrival, supports timely reperfusion where indicated, and minimises complications.[9][10][11]
• Establish equitable access to organised stroke units, stroke teams and referral centres, including access to a reference team or unit within 60 minutes where specified.[12][13][14]
• Increase one-month survival and functional independence after stroke, with stated targets including survival above 80% at one month and independence among 70% of survivors at three months; another section sets the survival objective above 85%.[14][15]
• Deliver early, individualised, multidisciplinary rehabilitation and support social, personal and occupational reintegration, including coordinated assistance for patients, families and carers.[16][17][18]
• Strengthen workforce training and interdisciplinary research on stroke prevention, treatment, rehabilitation, service efficiency, telemedicine and related priorities.[19][20][21]

Implementation

The strategy combines national coordination with implementation by Spain’s autonomous communities, whose health services retain responsibility for organising services, plans and programmes within their competencies.[22][2][23]Its delivery model links primary care, emergency medical services, hospitals, specialist stroke teams and units, rehabilitation services, social care, patients and families across the full care pathway.[12][24][25]

• Govern through the Ministry of Health and Consumer Affairs, the Directorate-General of the Quality Agency, the Office for Health Planning and Quality, the Health Information Institute, an Institutional Committee representing autonomous-community health authorities, and a Technical Committee involving clinical, public-health, rehabilitation, social-care and patient organisations.[22][2]
• Implement prevention through primary care, using opportunistic and active identification of people at risk, cardiovascular risk assessment, risk-factor management, health education and follow-up after stroke or transient ischaemic attack.[5][26][6]
• Organise emergency response through pre-hospital and in-hospital Stroke Code systems that enable rapid identification, notification, prioritisation, transfer and initiation of diagnostic and treatment processes.[27][28]
• Deliver acute care through clinical pathways, urgent neuroimaging and laboratory assessment, specialist neurological input, organised stroke-unit monitoring, early rehabilitation and fibrinolysis or other reperfusion treatment when clinically appropriate.[9][11][29][30]
• Use a tiered hospital network comprising hospitals with stroke teams, hospitals with geographically defined stroke units, and reference centres with advanced diagnostic, surgical and neurointerventional capacity.[13][31][32]
• Use telemedicine, agreed transfer protocols and, where appropriate, air transport to support geographically distant providers, reduce avoidable transfers and widen access to specialist assessment and thrombolytic treatment.[13][33][34]
• Coordinate rehabilitation across hospital, outpatient, home and longer-term settings through multidisciplinary teams, shared discharge information, functional assessment, compatible electronic records and health and social-care collaboration.[18][15][35]
• Support families and informal carers through information, training, administrative assistance, technical aids, resource maps, telephone advice, carer wellbeing measures and cooperation with patient and carer associations.[19][36]
• Develop continuing professional education for primary care, emergency services, stroke teams and units, including training on rapid identification, transfer, treatment and Stroke Code procedures.[20][37]
• Advance research through national and regional project calls, accredited networks and collaboration between hospitals, universities and other National Health System actors.[38][21]
• Evaluate implementation through indicators for all strategic areas, National Health System information-system data, agreed questionnaires, qualitative reports and standardised data collection across autonomous communities.[2][39][40]
• Monitor outcomes and service coverage using measures including hospital-discharge rates, primary-care coverage of hypertension and diabetes, survey-based vascular-risk prevalence, stroke mortality, treatment timing, survival, independence and rehabilitation assessments.[39][40][41][42][43]The supplied material does not provide a complete national reporting timetable, public-reporting process or sanctions framework.[2][39]

Monitoring & Evaluation

The Strategy includes a system for continuous evaluation of implementation across its five strategic areas, combining National Health System information-system data with an agreed questionnaire to address recognised gaps in pre-hospital, primary-care, outpatient and service-coordination information.[2][39]Indicators are intended to be feasible across Spain’s National Health System and compatible with autonomous-community stroke plans and programmes.[2]

• Monitor annual hospital-discharge rates for stroke per 100,000 population, disaggregated by autonomous community and sex, using hospital-discharge registers and population estimates.[39]
• Monitor primary-care coverage and survey-based prevalence of diagnosed hypertension, diabetes and obesity, with relevant breakdowns by autonomous community, sex and, for survey measures, age group.[40][41]
• Track smoking among people over 15 years and leisure-time physical activity among people aged 16 years and over through the National Health Survey.[42]
• Measure annual overall and premature stroke mortality per 100,000 population, using deaths coded under International Classification of Diseases codes 160 to 164 and age adjustment against the European standard population.[42][43]
• Assess acute-care performance through treatment-decision time after hospital arrival, with a target of no more than 60 minutes, alongside monitoring of vital signs, neurological status, complications, treatment outcomes and stroke-unit activity.[9][10][11]
• Track outcome objectives including survival above 80% one month after stroke and independence among 70% of survivors at three months, while a later formulation sets one-month survival above 85%.[14][15]
• Require functional assessment at the end of rehabilitation, record completed and continuing care in discharge reports, and make these reports immediately available to primary-care teams.[18]
• Evaluate public education through population surveys of knowledge retention and behaviour change, and through changes in access or treatment delays, supported where available by stroke registers.[44]
• Report continuing-training activity by evaluation period, accredited activities, credits, attendees and professional group; link research reports to strategic objectives and record each study’s budget, funder, status and reference.[45]

Governance arrangements support evaluation through the Institutional Committee, which assesses the relevance and feasibility of objectives, and through strategy committees that agree additional information needs and standardised collection criteria.[22][39][40]The supplied material does not specify a complete national reporting timetable, public reporting process, sanctions, or a detailed formal accountability mechanism.[2][46][37]

Costing & Financing

Stroke is presented as a substantial health-system, social and economic burden, with costs arising from hospital treatment, rehabilitation, medicines, outpatient care, lost productivity and informal care.[47][48][49][50]The Strategy does not provide a dedicated implementation budget, allocation formula, funding gap, financing plan or resource-mobilisation mechanism; its objectives are instead expected to be realistic in relation to available resources and autonomous-community responsibilities.[23]

• Recognise that stroke is estimated to consume 3% to 4% of healthcare expenditure in high-income countries and that 76% of direct healthcare costs occur during the first year, mainly through hospital care.[47]
• Note that European first-year stroke-cost estimates ranged from 20,000 to 30,000 euros, while one Spanish study estimated 5,338 euros per patient.[47]
• Record a 2003 societal estimate of 622 million euros in healthcare costs, 320 million euros in indirect costs and 297 million euros in informal-care costs.[49]
• Recognise that informal-care costs were estimated at 801.7 million to 1,243.9 million euros in a base case, rising to 1,125.3 million to 1,746.0 million euros under an alternative assumption concerning care hours attributable to comorbidities.[48]
• Support stroke research through Carlos III Health Institute funding of 2,947,124 euros for 30 projects in 2006-2007 and through funding for the Neurovascular Cooperative Research Network.[38]
• Consider resource requirements for implementation, including emergency transport, accredited referral centres, specialist staffing, stroke units and teams, telemedicine, rehabilitation provision, information systems, training and social-care coordination.[12][24][46][37]

Some interventions are described as potentially cost-saving or cost-reducing: fibrinolysis is characterised as not increasing costs while reducing disability, specialised urgent care and stroke units are associated with lower care-process costs, and telemedicine may avoid unnecessary transfers.[11][51][52][33]These statements do not supply quantified programme-level savings or economic assumptions.[11][33]